Literature DB >> 32182291

PURL: NPH insulin: It remains a good option.

Ben Arthur1, Ashley Smith1, Nick Bennett1, David Bury1, Bob Marshall1.   

Abstract

NPH insulin holds its own against basal insulin analogs-and it's cheaper.

Entities:  

Year:  2020        PMID： 32182291      PMCID： PMC7156125     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  6 in total

Review 1.  Insulin Access and Affordability Working Group: Conclusions and Recommendations.

Authors:  William T Cefalu; Daniel E Dawes; Gina Gavlak; Dana Goldman; William H Herman; Karen Van Nuys; Alvin C Powers; Simeon I Taylor; Alan L Yatvin
Journal:  Diabetes Care       Date:  2018-05-08       Impact factor: 19.112

2.  Long-term outcomes of analogue insulin compared with NPH for patients with type 2 diabetes mellitus.

Authors:  Julia C Prentice; Paul R Conlin; Walid F Gellad; David Edelman; Todd A Lee; Steven D Pizer
Journal:  Am J Manag Care       Date:  2015-03-01       Impact factor: 2.229

Review 3.  Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.

Authors:  K Horvath; K Jeitler; A Berghold; S H Ebrahim; T W Gratzer; J Plank; T Kaiser; T R Pieber; A Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

4.  Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.

Authors:  Kasia J Lipska; Melissa M Parker; Howard H Moffet; Elbert S Huang; Andrew J Karter
Journal:  JAMA       Date:  2018-07-03       Impact factor: 56.272

5.  Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.

Authors:  James J Chamberlain; William H Herman; Sandra Leal; Andrew S Rhinehart; Jay H Shubrook; Neil Skolnik; Rita Rastogi Kalyani
Journal:  Ann Intern Med       Date:  2017-03-14       Impact factor: 25.391

6.  Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.

Authors:  Lydia W Turner; David Nartey; Randall S Stafford; Sonal Singh; G Caleb Alexander
Journal:  Diabetes Care       Date:  2013-11-06       Impact factor: 17.152
  6 in total
  1 in total

Review 1.  Current State and Principles of Basal Insulin Therapy in Type 2 Diabetes.

Authors:  Hernando Vargas-Uricoechea
Journal:  J Clin Med Res       Date:  2022-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.